Lactose (India) Ltd

Lactose (India) Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Lactose (India) Ltd

₹ 98.4 -0.72%
11 Jun - close price
lactoseindialimited.com BSE: 524202
About

Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work[1]

Key Points

Business Overview:[1][2]
LIL, associated with the Kerry Group, is involved in the production of pharmaceuticals, drugs, medicines, chemicals, and food products. The company operates as a manufacturer, processor, exporter, importer, and distributor across multiple categories, including:
a) all types of food—finished, semi-finished, processed, and unprocessed;
b) dairy products such as milk cream, ice cream, curd, paneer, cheese, and sweets;
c) pharmaceuticals, bulk drugs, and medicines; and
d) chemicals, compounds, derivatives, and intermediates.

Website BSE
  • Market Cap ₹ 139 Cr.
  • Current Price ₹ 98.4
  • High / Low ₹ 247 / 84.3
  • Stock P/E 26.9
  • Book Value ₹ 41.7
  • Dividend Yield 0.00 %
  • ROCE 12.9 %
  • ROE 9.75 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 136% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.61% over last 3 years.
  • Promoters have pledged 26.1% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
14.35 9.62 13.17 17.02 25.99 27.47 24.43 32.60 29.40 29.46 30.45 28.72 27.77
8.85 7.34 10.82 14.29 21.99 23.70 21.04 26.88 23.28 23.88 25.44 25.75 24.36
Operating Profit 5.50 2.28 2.35 2.73 4.00 3.77 3.39 5.72 6.12 5.58 5.01 2.97 3.41
OPM % 38.33% 23.70% 17.84% 16.04% 15.39% 13.72% 13.88% 17.55% 20.82% 18.94% 16.45% 10.34% 12.28%
0.30 0.23 0.20 0.16 0.14 0.28 0.26 0.28 0.31 0.22 0.30 0.56 0.37
Interest 1.23 1.24 1.31 1.55 1.84 1.55 1.31 1.21 1.17 1.26 1.37 1.64 1.84
Depreciation 1.19 1.16 1.17 1.17 1.19 1.19 1.20 1.20 1.63 1.31 1.33 1.35 1.39
Profit before tax 3.38 0.11 0.07 0.17 1.11 1.31 1.14 3.59 3.63 3.23 2.61 0.54 0.55
Tax % 23.96% 18.18% -14.29% 11.76% 20.72% 26.72% 28.95% 27.02% 33.88% 29.72% 22.22% 59.26% -18.18%
2.57 0.09 0.09 0.14 0.89 0.96 0.81 2.63 2.40 2.27 2.03 0.22 0.64
EPS in Rs 2.04 0.07 0.07 0.11 0.71 0.76 0.64 2.09 1.91 1.80 1.61 0.16 0.45
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
22 24 34 36 31 41 40 35 46 66 114 116
21 19 24 24 25 31 31 29 34 54 95 99
Operating Profit 1 5 10 11 6 10 9 6 12 11 19 17
OPM % 5% 22% 30% 32% 18% 24% 23% 18% 27% 17% 17% 15%
2 0 1 1 1 0 0 0 1 1 1 1
Interest 1 3 4 4 5 5 6 5 5 6 5 6
Depreciation 2 2 3 3 4 4 4 4 5 5 5 5
Profit before tax 0 1 4 4 -3 1 0 -3 3 1 10 7
Tax % 60% 42% 28% 36% -52% 33% 30% -24% 23% 18% 30% 25%
0 0 3 3 -1 1 0 -2 2 1 7 5
EPS in Rs 0.04 0.59 3.17 2.87 -1.32 0.71 0.07 -2.17 1.95 0.96 5.39 3.66
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 17%
5 Years: 24%
3 Years: 36%
TTM: 2%
Compounded Profit Growth
10 Years: 26%
5 Years: 136%
3 Years: 29%
TTM: -24%
Stock Price CAGR
10 Years: 13%
5 Years: 39%
3 Years: 6%
1 Year: -43%
Return on Equity
10 Years: 5%
5 Years: 6%
3 Years: 10%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 9 10 10 10 10 11 13 13 13 13
Reserves 7 7 12 17 22 24 24 24 27 28 35 46
23 39 37 34 38 36 39 46 41 38 39 57
22 25 26 24 13 11 10 7 10 22 14 18
Total Liabilities 60 80 83 85 83 82 84 88 90 101 101 133
28 62 61 64 63 60 62 59 59 56 55 52
CWIP 15 1 1 1 0 1 0 4 0 0 0 10
Investments 1 1 0 0 0 0 0 1 1 0 0 0
16 15 21 20 19 20 22 25 30 45 46 71
Total Assets 60 80 83 85 83 82 84 88 90 101 101 133

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7 13 1 8 0 5 7 2 8 8 9 -0
-21 -23 3 -5 -2 -2 -3 -6 -1 -1 -2 -16
13 10 -5 -3 4 -5 -4 5 -8 -8 -6 19
Net Cash Flow -1 -1 -0 -0 3 -2 1 1 -0 -1 1 3

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 125 83 96 91 63 62 64 67 90 69 49 68
Inventory Days 69 129 344 440 456 384 471 587 343 344 119 171
Days Payable 308 273 340 559 330 242 202 153 195 275 59 74
Cash Conversion Cycle -114 -61 100 -27 188 204 333 501 238 138 109 165
Working Capital Days -20 -61 -33 -23 18 43 76 125 100 88 73 120
ROCE % -3% 8% 13% 15% 4% 9% 8% 3% 10% 9% 18% 13%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
53.79% 53.79% 53.79% 53.79% 53.79% 53.77% 53.66% 53.65% 53.65% 53.65% 53.65% 53.65%
0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%
45.59% 45.59% 45.59% 45.59% 45.59% 45.62% 45.73% 45.72% 45.74% 45.73% 45.73% 45.74%
No. of Shareholders 15,77715,94315,94015,90215,89815,95016,08816,24516,63016,99817,11517,082

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings